LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 47 filers reported holding LOGICBIO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $32,000 | +300.0% | 115,925 | +439.2% | 0.00% | – |
Q2 2022 | $8,000 | -38.5% | 21,500 | +14.4% | 0.00% | – |
Q1 2022 | $13,000 | -69.8% | 18,800 | +1.1% | 0.00% | – |
Q4 2021 | $43,000 | -14.0% | 18,600 | +70.6% | 0.00% | – |
Q3 2021 | $50,000 | -20.6% | 10,900 | -23.5% | 0.00% | – |
Q2 2021 | $63,000 | -74.6% | 14,250 | -56.1% | 0.00% | – |
Q4 2020 | $248,000 | – | 32,430 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lion Point Capital, LP | 500,000 | $2,220,000 | 0.38% |
Orbimed Advisors | 8,466,783 | $37,593,000 | 0.38% |
Sio Capital Management, LLC | 182,630 | $811,000 | 0.20% |
Tibra Equities Europe Ltd | 76,500 | $340,000 | 0.10% |
SAMLYN CAPITAL, LLC | 1,420,452 | $6,308,000 | 0.09% |
PURA VIDA INVESTMENTS, LLC | 249,256 | $1,107,000 | 0.03% |
Trexquant Investment LP | 46,229 | $205,000 | 0.02% |
SANDERS MORRIS HARRIS LLC | 15,000 | $67,000 | 0.01% |
Baker Brothers Advisors | 451,478 | $2,005,000 | 0.01% |
Verition Fund Management LLC | 208,099 | $924,000 | 0.01% |